Natixis Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Buy
36,086
+8,025
+29% +$559K ﹤0.01% 1073
2025
Q4
$1.86M Sell
28,061
-81,203
-74% -$5.25M ﹤0.01% 1067
2025
Q3
$7.35M Sell
109,264
-117,827
-52% -$9.32M 0.01% 743
2025
Q2
$19.8M Buy
227,091
+76,147
+50% +$5.97M 0.03% 479
2025
Q1
$10.3M Sell
150,944
-42,588
-22% -$3.48M 0.02% 627
2024
Q4
$15.1M Buy
193,532
+158,124
+447% +$11.7M 0.03% 534
2024
Q3
$2.37M Sell
35,408
-1,056,986
-97% -$86.8M ﹤0.01% 1040
2024
Q2
$124M Sell
1,092,394
-63,606
-6% -$8.04M 0.27% 81
2024
Q1
$160M Buy
1,156,000
+26,430
+2% +$3.32M 0.37% 54
2023
Q4
$140M Buy
1,129,570
+661,584
+141% +$67.6M 0.37% 53
2023
Q3
$43.7M Buy
467,986
+413,407
+757% +$46.6M 0.13% 172
2023
Q2
$7.01M Buy
54,579
+2,295
+4% +$278K 0.02% 619
2023
Q1
$6.07M Buy
52,284
+11,683
+29% +$1.31M 0.02% 637
2022
Q4
$4.6M Buy
40,601
+6,736
+20% +$740K 0.02% 703
2022
Q3
$2.73M Sell
33,865
-3,054
-8% -$259K 0.01% 811
2022
Q2
$2.75M Buy
+36,919
New +$3.37M 0.01% 811
2014
Q3
Sell
-27,508
Closed -$273K 1060
2014
Q2
$273K Buy
27,508
+6,240
+29% +$55.3K ﹤0.01% 1184
2014
Q1
$220K Buy
+21,268
New +$220K ﹤0.01% 1173

Other funds holding DXCM

Natixis Advisors's DXCM Position: Q1 2026 in Review

Natixis Advisors increased its DexCom (DXCM) stake by 29% in Q1 2026, buying an estimated $559K and bringing the position to 36,086 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Natixis Advisors first reported a position in DXCM in Q1 2014 and has held it in 18 quarters since. The position peaked at $160M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Natixis Advisors held 36,086 shares of DexCom worth $2.27M as of Q1 2026.
  • Natixis Advisors bought 8,025 DexCom shares in Q1 2026, an estimated $559K.
  • DexCom made up ﹤0.01% of Natixis Advisors's portfolio in Q1 2026, its #1073 holding.
  • Natixis Advisors first reported a position in DexCom in Q1 2014 and has held it in 18 quarters since.
  • Natixis Advisors's DexCom position peaked at $160M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.